UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analyzing Banking Risk (Fourth Edition): A Framework for Assessing Corporate Governance and Risk Management

1, 2020

Volltextzugriff (PDF)

Analyzing banking risk: A framework for assessing corporate governance and financial risk management

1999

Volltextzugriff (PDF)

Analyzing Banking Risk: A Framework for Assessing Corporate Governance and Risk Management

3rd ed., 2009

Volltextzugriff (PDF)

Analyzing and Managing Banking Risk: A Framework for Assessing Corporate Governance and Financial Risk

2, 2003

Volltextzugriff (PDF)

Postmarketing Safety‐Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002–2014: Similarities and Differences With New Molecular Entities

Clinical pharmacology and therapeutics, 2020-12, Vol.108 (6), p.1243-1253

2020

Volltextzugriff (PDF)

The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes

Clinical pharmacology and therapeutics, 2021-12, Vol.110 (6), p.1512-1525

2021

Volltextzugriff (PDF)

ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance

Drug safety, 2021-01, Vol.44 (1), p.83-94

2021

Volltextzugriff (PDF)

Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology

Journal of biomedical informatics, 2018-07, Vol.83, p.73-86

2018

Volltextzugriff (PDF)

Postmarketing safety-related regulatory actions for new therapeutic biologics approved in the U.S. 2002 – 2014: Similarities and differences with new molecular entities

Clinical pharmacology and therapeutics, 2020-09, Vol.108 (6), p.1243-1253

2020

Volltextzugriff (PDF)

Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014

Clinical pharmacology and therapeutics, 2018-08, Vol.104 (2), p.390-400

2018

Volltextzugriff (PDF)

Analyzing Banking Risk (3rd Edition): A Framework for Assessing Corporate Governance and Financial Risk

2009

Volltextzugriff (PDF)

Analyzing Banking Risk (4th Edition)

2020

Volltextzugriff (PDF)

Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration

Pharmacoepidemiology and drug safety, 2012-06, Vol.21 (6), p.565-570

2012

Volltextzugriff (PDF)

Validating a Framework for Coding Patient-Reported Health Information to the Medical Dictionary for Regulatory Activities Terminology: An Evaluative Study

JMIR medical informatics, 2018-08, Vol.6 (3), p.e42-e42

2018

Volltextzugriff (PDF)

Analyzing Banking Risk : A Framework for Assessing Corporate Governance and Risk Management, Third Edition

2009

Volltextzugriff (PDF)

Analyzing and Managing Banking Risk : A Framework for Assessing Corporate Governance and Financial Risk Management, Second Edition

2003

Volltextzugriff (PDF)

Analyzing Banking Risk: A Framework for Assessing Corporate Governance and Risk Management

International Bank for Reconstruction and Development, Apr 2009, 440 pp, 2009, Vol.3

2009

Volltextzugriff (PDF)